Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy von Calcutt, Nigel A, Allendoerfer, Karen L, Mizisin, Andrew P, Middlemas, Alicia, Freshwater, Jason D, Burgers, Monica, Ranciato, Rigel, Delcroix, Jean-Dominique, Taylor, Frederick R, Shapiro, Renee, Strauch, Kathy, Dudek, Henryk, Engber, Thomas M, Galdes, Alphonse, Rubin, Lee L, Tomlinson, David R

Volltext

Hedgehog Proteins Play A Role In Peripheral Nerve Regeneration von Engber, Tm, Allendoerfer, Kl, Berg, A, Drake, E, Mahanthappa, N, Mozell, R, Pepicelli, C, Ranciato, R, Reilly, Jo, Sah, D, Wang, S, Galdes, A.

Volltext

390P Vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: Update... von Hamilton, E.P., Han, H., Schott, A., Tan, A., Nanda, R., Juric, D., Hunter, N., Munster, P., Fang, B., Zahrah, G., Ranciato, J., Gedrich, R., Zhi, E., Zhang, Y., Tan, W., Mather, C., Perkins, J., Anderson, S., Hurvitz, S.A.

Volltext

256TiP TACTIVE-E: Phase Ib study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, in combination with everolimus in ER+/human epidermal growth... von Philipovskiy, A., Schott, A., Cortés, J., Ivie, S., Gedrich, R., Zhi, E., Ranciato, J., Perkins, J., Hamilton, E.

Volltext

154TiP TACTIVE-N: Open-label, randomized, noncomparative neoadjuvant phase 2 study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, or anastroz... von Fasching, P.A., Clifton, K., Katashvili, Z., Nemsadze, G., Makharadze, T., Arkania, E., Gogishvili, M., Lachowicz, M., Gedrich, R., Ranciato, J., Zhi, E., Perkins, J., Jañez, N. Martinez, Hurvitz, S.A.

Volltext